3-取代吲哚-2-酮类化合物的设计、合成及抗肿瘤活性研究 |
投稿时间:2014-11-03 修订日期:2015-01-20 点此下载全文 |
引用本文:周浩,周峰,周有骏.3-取代吲哚-2-酮类化合物的设计、合成及抗肿瘤活性研究[J].药学实践杂志,2015,33(2):131~133,142 |
摘要点击次数: 1256 |
全文下载次数: 138 |
|
基金项目:国家自然科学基金(21172260) |
|
中文摘要:目的 设计合成对微管蛋白和血管内皮细胞生长因子受体2(VEGFR-2)激酶具有双重抑制作用的3-取代吲哚-2-酮类化合物,考察其体外抑瘤活性。 方法 以取代的苯胺为起始原料,经缩合、环合、还原、取代等反应制得系列目标化合物,并考察该系列化合物对微管蛋白和肿瘤细胞的抑制活性。 结果 共合成了11个新的目标化合物。实验结果显示,化合物j9对微管蛋白和VEGFR-2激酶具有双重抑制活性。所有目标化合物对3种肿瘤细胞株均有中等强度的抑制活性。 结论 该类化合物是一类具有多靶点作用的抗肿瘤化合物。 |
中文关键词:血管靶向药物 3-取代吲哚-2-酮类化合物 微管蛋白抑制活性 激酶抑制活性 |
|
Design, synthesis and anti-tumor activities in vitro of novel 3-substituted indolin-2-one compounds |
|
|
Abstract:Objective To compose and evaluate anti-tumor activities of 3-substituted indole-2-one compounds which may have dual inhibitory activities against both tubulin protein and VEGFR-2 tyrosine kinase. Methods Target compounds were prepared starting from substituted aniline via condensation, cyclization and reduction. Results 11 target compounds were synthesized and all the compounds displayed moderate anti-proliferative activities against three tumor cell lines. Compound j9 showed a certain inhibitory activity against both VEGFR-2 kinase and tubulin protein in vitro. Conclusion This series of indolin-2-one derivatives were found to be a novel kind of multi-target inhibitor. |
keywords:vascular targeting drug 3-substituted indolin-2-one compounds tubulin inhibitory activities kinase inhibitory activities |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |